Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma.
Hongyan HuangMeifang HeYanbin ZhangBo ZhangZubiao NiuYou ZhengWen LiPeilin CuiXiaoning WangQiang SunPublished in: Signal transduction and targeted therapy (2020)